Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China
· Delayed Price · Currency is CNY 54.94
-0.62 (-1.12%)
At close: Mar 9, 2026
SHA:600276 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 364,326 | 291,858 | 287,598 | 245,741 | 323,076 | 591,745 | Upgrade
|
| Market Cap Growth | 26.51% | 1.48% | 17.03% | -23.94% | -45.40% | 53.53% | Upgrade
|
| Enterprise Value | 324,461 | 269,604 | 270,642 | 228,393 | 306,010 | 576,180 | Upgrade
|
| Last Close Price | 54.94 | 45.73 | 44.85 | 38.07 | 49.91 | 91.20 | Upgrade
|
| PE Ratio | 47.35 | 46.06 | 66.85 | 62.91 | 71.32 | 93.51 | Upgrade
|
| Forward PE | 40.23 | 49.34 | 56.94 | 49.45 | 52.14 | 85.65 | Upgrade
|
| PS Ratio | 11.76 | 10.43 | 12.60 | 11.55 | 12.47 | 21.34 | Upgrade
|
| PB Ratio | 6.07 | 6.33 | 7.01 | 6.40 | 9.08 | 19.22 | Upgrade
|
| P/TBV Ratio | 6.28 | 6.58 | 7.27 | 6.59 | 9.35 | 19.62 | Upgrade
|
| P/FCF Ratio | 37.22 | 53.52 | 46.69 | - | 126.49 | 205.64 | Upgrade
|
| P/OCF Ratio | 30.49 | 39.32 | 37.63 | 194.22 | 76.58 | 172.42 | Upgrade
|
| PEG Ratio | - | 4.11 | 3.47 | 10.27 | 4.78 | 3.53 | Upgrade
|
| EV/Sales Ratio | 10.47 | 9.63 | 11.86 | 10.74 | 11.81 | 20.78 | Upgrade
|
| EV/EBITDA Ratio | 37.62 | 37.48 | 55.89 | 63.46 | 71.83 | 85.74 | Upgrade
|
| EV/EBIT Ratio | 41.53 | 41.63 | 64.81 | 74.65 | 81.29 | 91.87 | Upgrade
|
| EV/FCF Ratio | 33.15 | 49.44 | 43.94 | - | 119.81 | 200.23 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.02 | 0.02 | 0.37 | 0.04 | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.02 | 0.01 | - | 0.06 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.67 | -0.54 | -0.51 | -0.43 | -0.52 | -0.53 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.71 | -3.47 | -4.29 | -4.59 | -4.36 | -2.44 | Upgrade
|
| Net Debt / FCF Ratio | -4.13 | -4.58 | -3.37 | 22.71 | -7.27 | -5.71 | Upgrade
|
| Asset Turnover | 0.53 | 0.60 | 0.53 | 0.52 | 0.70 | 0.89 | Upgrade
|
| Inventory Turnover | 1.61 | 1.64 | 1.50 | 1.44 | 1.80 | 1.98 | Upgrade
|
| Quick Ratio | 5.95 | 8.62 | 10.74 | 7.36 | 7.72 | 6.70 | Upgrade
|
| Current Ratio | 6.55 | 9.72 | 12.25 | 8.50 | 8.88 | 7.44 | Upgrade
|
| Return on Equity (ROE) | 14.34% | 14.55% | 10.77% | 10.31% | 13.51% | 22.64% | Upgrade
|
| Return on Assets (ROA) | 8.37% | 8.62% | 6.06% | 4.69% | 6.36% | 12.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 32.36% | 27.67% | 18.16% | 15.12% | 23.90% | 44.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.90% | 13.90% | 10.10% | 7.90% | 10.50% | 20.30% | Upgrade
|
| Earnings Yield | 2.05% | 2.17% | 1.50% | 1.59% | 1.40% | 1.07% | Upgrade
|
| FCF Yield | 2.69% | 1.87% | 2.14% | -0.30% | 0.79% | 0.49% | Upgrade
|
| Dividend Yield | 0.36% | 0.44% | 0.45% | 0.42% | 0.32% | 0.18% | Upgrade
|
| Payout Ratio | 17.06% | 20.12% | 23.77% | 26.00% | 23.54% | 16.07% | Upgrade
|
| Buyback Yield / Dilution | -1.59% | -0.15% | 1.20% | -0.36% | 0.18% | 0.03% | Upgrade
|
| Total Shareholder Return | -1.23% | 0.29% | 1.65% | 0.06% | 0.50% | 0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.